Legal & General Group Plc decreased its stake in shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN – Free Report) by 60.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 37,410 shares of the business services provider’s stock after selling 56,440 shares during the period. Legal & General Group Plc owned 0.11% of Cross Country Healthcare worth $679,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in CCRN. Barclays PLC boosted its position in shares of Cross Country Healthcare by 117.5% in the third quarter. Barclays PLC now owns 80,277 shares of the business services provider’s stock valued at $1,078,000 after acquiring an additional 43,372 shares during the period. Amundi grew its position in shares of Cross Country Healthcare by 385.4% during the 4th quarter. Amundi now owns 26,494 shares of the business services provider’s stock worth $483,000 after purchasing an additional 21,036 shares in the last quarter. Yakira Capital Management Inc. bought a new position in shares of Cross Country Healthcare during the fourth quarter worth approximately $1,013,000. Chicago Capital Management LLC bought a new position in shares of Cross Country Healthcare during the fourth quarter worth approximately $7,300,000. Finally, Sei Investments Co. raised its position in shares of Cross Country Healthcare by 7.3% in the fourth quarter. Sei Investments Co. now owns 143,380 shares of the business services provider’s stock valued at $2,604,000 after buying an additional 9,816 shares in the last quarter. Institutional investors and hedge funds own 96.03% of the company’s stock.
Wall Street Analysts Forecast Growth
CCRN has been the subject of a number of recent analyst reports. JMP Securities reiterated a “market perform” rating on shares of Cross Country Healthcare in a research report on Thursday, February 6th. StockNews.com assumed coverage on shares of Cross Country Healthcare in a research report on Tuesday. They set a “hold” rating for the company. Finally, Barrington Research reissued a “market perform” rating and issued a $18.61 target price on shares of Cross Country Healthcare in a report on Friday, March 14th. Six analysts have rated the stock with a hold rating, According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $18.41.
Cross Country Healthcare Stock Down 1.7 %
NASDAQ:CCRN opened at $13.51 on Tuesday. Cross Country Healthcare, Inc. has a twelve month low of $9.58 and a twelve month high of $18.50. The stock’s 50-day simple moving average is $15.27 and its 200 day simple moving average is $15.36. The firm has a market capitalization of $442.94 million, a PE ratio of -270.15, a price-to-earnings-growth ratio of 3.32 and a beta of 0.25.
Cross Country Healthcare Profile
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Recommended Stories
- Five stocks we like better than Cross Country Healthcare
- What is Put Option Volume?
- Best Defense Stocks in 2025… So Far
- Insider Trades May Not Tell You What You Think
- Alphabet Rebounds After Strong Earnings and Buyback Announcement
- What Does a Stock Split Mean?
- Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret?
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.